GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very sensitive, ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

Some healthcare professionals are unaware of the link between the menopause and the potentially-deadly condition, which affects 7.2million people in the UK.

A set of chameleon-like immune cells could be contributing to severe asthma in some patients.Intermediate group 2 i ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

LONDON - GSK plc (LSE/NYSE: GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

How can a long-standing cough that does not produce phlegm, and stops as soon as you fall asleep, be cured by watching a ...

A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...